The penalty is a new power allowed by the Inflation Reduction Act, which became law in August 2022. The federal government is working to quell the rise of drug prices by fining drugmakers with cost increases that outpace the rate of inflation. In March, the White House listed 27 Medicare Part B medications subject to penalties.
The 48 drugs that are facing enforced rebates in January are between $1 and $2,786 per dose, the White House said in a Dec. 14 news release. Sixteen other therapies could be added to the fray.
Access the list of 48 drugs here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.